title: Hypereosinophilic syndrome associated with regulatory T-cell disruption as a complication of stem cell transplantation.
authors.affiliation: Department of Family Medicine, South Pointe Hospital, Warrensville Heights, Ohio, USA.
authors.forename: T
authors.initials: T
authors.lastname: Kersey-Barrett
authors.forename: A
authors.initials: A
authors.lastname: Glick
authors.forename: D
authors.initials: D
authors.lastname: Wald
authors.forename: H
authors.initials: H
authors.lastname: Meyerson
authors.forename: H
authors.initials: H
authors.lastname: Tcheurekdjian
mesh_terms: D000361:Agammaglobulinemia; D003873:Dermatitis, Exfoliative; D018572:Disease-Free Survival; D004802:Eosinophilia; D006505:Hepatitis; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D053645:Interleukin-2 Receptor alpha Subunit / Q000096:biosynthesis; D053699:Interleukin-7 Receptor alpha Subunit / Q000096:biosynthesis; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology / Q000601:surgery*; D011014:Pneumonia; D011183:Postoperative Complications / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D053645:Interleukin-2 Receptor alpha Subunit; D053699:Interleukin-7 Receptor alpha Subunit